Perbedaan Merck Tbk. dan Charlie Hospital Semarang Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 678,4 M, volume 24 jam 25,57 jt). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 2,5× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (25,57 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 678,4 M |
Volume | 37,6 rb | 25,57 jt |
Lot | 376 | 255,67 rb |
Perputaran | 144,47 jt | 6,57 M |
Harga Rata-rata | 3.842,23 | 256,8 |
Nilai Transaksi | 144,47 jt | 6,57 M |
Harga Ekuilibrium Indikatif | 3.840 | 258 |
Volume Ekuilibrium Indikatif | 7 | 110 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →